Provided by Tiger Trade Technology Pte. Ltd.

Palisade Bio Inc.

2.01
-0.0900-4.29%
Post-market: 2.040.0300+1.49%17:13 EDT
Volume:1.62M
Turnover:3.32M
Market Cap:349.74M
PE:-9.98
High:2.10
Open:2.10
Low:2.00
Close:2.10
52wk High:2.86
52wk Low:0.5300
Shares:174.00M
Float Shares:130.00M
Volume Ratio:0.97
T/O Rate:1.24%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2015
EPS(LYR):-0.3014
ROE:-51.37%
ROA:-32.98%
PB:2.87
PE(LYR):-6.67

Loading ...

Maxim Group Sticks to Its Buy Rating for Palisade Bio (PALI)

TIPRANKS
·
Aug 12

Palisade Bio (PALI) Receives a New Rating from B. Riley Securities

TIPRANKS
·
Aug 12

Imunon Q2 Net Loss Widens Slightly as R&D Costs Rise

Reuters
·
Aug 11

Palisade Bio (PALI) Receives a Buy from Oppenheimer

TIPRANKS
·
Aug 11

Palisade Bio Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 11

Palisade Bio Q2 EPS $(0.05), Inline, Sales $500.000K

Benzinga Earnings
·
Aug 11

DiaMedica Q2 Net Loss Widen Less than Expected

Reuters
·
Aug 11

Palisade Bio Q2 Net Loss Widens on Higher R&D Costs

Reuters
·
Aug 11

Palisade Bio Q2 FY26 Net Loss Widens 280% to $10.57 Million

Reuters
·
Aug 11

Palisade Bio Q2 EPS USD -0.05

THOMSON REUTERS
·
Aug 11

Palisade Bio Reports Second Quarter 2026 Financial Results and Highlights Continued Advancement of Pali-2108 into Phase 2 Development

THOMSON REUTERS
·
Aug 11

Palisade Bio Reports Second Quarter 2026 Financial Results and Highlights Continued Advancement of PALI-2108 Into Phase 2 Development

GlobeNewswire
·
Aug 11

Palisade Bio Inc Expected to Post a Loss of 5 Cents a Share - Earnings Preview

Reuters
·
Aug 08

Palisade Bio Inc : Oppenheimer Initiates Coverage with Outperform Rating; Target Price $8

THOMSON REUTERS
·
Jul 23

Insider Power Move: Palisade Bio Director Makes Bold New Share Grab

TIPRANKS
·
Jul 11

Palisade Bio Director Robert Baltera Jr Acquires USD 88,687.50 in Common Shares

Reuters
·
Jul 11

Palisade Bio to Meet Investors at Leerink Partners Therapeutics Forum July 14-15

Reuters
·
Jul 10

Palisade Bio Director Robert Baltera Jr. Acquires USD 101,044 of Common Shares

Reuters
·
Jul 09

Palisade Bio Director Robert Baltera Jr Acquires USD 59,400 in Common Shares

Reuters
·
Jul 07

Analysts Are Bullish on Top Healthcare Stocks: Coya Therapeutics, Inc. (COYA), Palisade Bio (PALI)

TIPRANKS
·
Jul 06